SAGE Therapeutics
Cambridge
About SAGE Therapeutics
SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $2.7B
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2020)
- Ticker: nasdaq:SAGE
- Website: sagerx.com
- Phone: +1 617 299 8380
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sage-therapeutics-143773 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.